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Cryptosporidium is a parasite that causes the majority of
waterborne protozoan outbreaks of gastrointestinal dis-
ease worldwide.1 Cryptosporidiosis usually presents as
self-limiting, although often prolonged, diarrhea with
abdominal pain, nausea, vomiting and low-grade fever.
Infection can be life threatening in some severely immu-
nocompromised groups.2 Post infection sequelae have
also been reported.3 On a global level, Cryptosporidium
hominis and Cryptosporidium parvum cause the majority
of human infections and drinking waterborne outbreaks.
Recently, Cryptosporidium cuniculus has also caused a
sizeable waterborne outbreak.4 Molecular detection of
human infective Cryptosporidium species is usually based
on conserved housekeeping genes, as is the case for other
microorganisms.5 However, novel detection targets have
been investigated for Cryptosporidium, but previous
investigations aiming to identify C. hominis and C. par-
vum speciﬁc genes had limited success because the
majority of putative species-speciﬁc genes were subse-
quently found to be present in the other species.6,7 This
was attributed to the limited numbers of genome sequen-
ces available and their low quality that hindered the
accurate prediction of genes’ presence. Nevertheless, evi-
dence was found for one C. hominis speciﬁc gene (Chos-
1), which was further validated independently using
comparative genomics of newly sequenced clinical iso-
lates.8 Chos-1 has a telomeric location and the predicted
secreted protein of 50 kDa has interesting features,
(highly glycosylated, serine rich and several internal
repeats), suggestive of a role in host pathogen interac-
tion.6 It is plausible that other Cryptosporidium species-
speciﬁc genes and virulence factors are also located at
the telomeres. Subtelomeres are hotspots for genetic
recombination in other parasitic protozoa, resulting in
signiﬁcant chromosome length and sequence composi-
tion polymorphisms and an over-representation of
highly-diverged loci which have been utilized for dis-
criminatory diagnostic purposes.9-12
Thanks to decreased costs and technological advan-
ces, an increasing number of full genome sequences are
becoming available for Cryptosporidium spp. and are
contributing to improved comparative genomics analy-
ses. While many investigators used these genomes to
identify genes and proteins based on their presence in
other parasites and bacteria, we have continued to look
for species-speciﬁc genes that are likely to be involved
in host parasite interaction and virulence. In addition,
these genes provide a source of highly speciﬁc and
stable detection markers. In this study, we used an
increased number of genome sequences to identify
species-speciﬁc genes, focusing on genes close to the
chromosome ends. Subsequently, primers and probes
targeting these loci were designed and evaluated as
novel real-time PCR assays for the speciﬁc detection
of the major human infective waterborne parasites
C. hominis and C. parvum.
Previous investigation of putative species-speciﬁc
genes led to the characterization of the telomeric Chos-1
gene.6 This ﬁnding suggested that further genes are likely
to be analogously positioned and warranted further
investigation of subtelomeric regions of C. hominis and
C. parvum genome sequences. In the ﬁrst instance, the
reference genome sequences of C. hominis TU502 (gp60
subtype IaA25R3) 13 and C. parvum Iowa (gp60 subtype
IIaA15G2R1) 14 were retrieved from CryptoDB (http://
cryptodb.org) and used for analysis. Subsequently, geno-
mic data of newly sequenced genomes from C. hominis
and C. parvum clinical isolates (UKH4 gp60 subtype
IaA14R3 and UKP6 gp60 IIaA15G2R1, respectively)
were used to verify our ﬁndings.15 Comparative analysis
of sequence data was achieved by aligning subtelomeric
regions spanning 30000 bp from the 50- and 30-ends of
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the 8 C. hominis and C. parvum chromosomes using the
Artemis Comparison Tool (ACT) 16 http://www.webact.
org/WebACT/home. The subtelomeric regions were
scanned in order to identify species-speciﬁc coding
sequences. The speciﬁcity of these sequences was further
validated against other Cryptosporidium isolates with dif-
ferent gp60 subtypes: 2 C. hominis (UKH5 gp60
IbA10G2, UKH3 gp60 IbA10G2) and 4 C. parvum
(UKP2 gp60 IIaA19G1R2, UKP3 gp60 IIaA18G2R1,
UKP7 gp60 IIaA17G1R1, UKP8 gp60 IIdA22G1) using a
standalone nucleotide blast test generated using BioEdit
(version 7.2.5) and against all non-Cryptosporidium iso-
lates using blastn software tool provided by NCBI
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPED
BlastSearch).
The analysis showed that a 14000 bp stretch of geno-
mic sequence was putatively speciﬁc to C. parvum and
missing from C. hominis along the subtelomeric arm
extending from the 50 telomeric repeat (50-AAACCT-30)
on chromosome 5 (Fig. 1). In C. parvum, a 419 bp stretch
of genomic sequence was missing at the 30 telomeric end
of chromosome 5 and therefore putatively C. hominis
speciﬁc. Four open reading frames (ORFs) were encoded
within the C. parvum speciﬁc sequence and the C. homi-
nis speciﬁc sequence partially spanned a single ORF.
Two of the C. parvum speciﬁc ORFs are the result of a C.
parvum speciﬁc gene duplication event of gene
cgd5_4580, which is located at the subtelomeric 30-end
of chromosome 6 in C. parvum, and which contains an
ortholog in C. hominis called Chro.50507. The third
open reading frame, identiﬁed as gene cgd6_5500, also
contains an ortholog in C. hominis, which has non syn-
tenic localization compared to its C. parvum counterpart
as it is located on a different chromosome. The fourth
coding sequence, Cgd6_5510 (Cops-2) encoding an insu-
linase-like peptidase, was wholly speciﬁc to C. parvum,
and hence selected for inclusion in this study. The geno-
mic sequence identiﬁed in C. hominis, Chro.00007
(Chos-2), was not entirely species-speciﬁc, with an
orthologous stretch of 100 bp sequence identiﬁed at the
30 end of chromosome 7 in C. parvum. However, the
degree of divergence for this orthologous segment (88%
nucleotide similarity) and the speciﬁcity of the remaining
319 bp stretch warranted inclusion of this marker for dis-
criminatory purposes. Chos-1, Chos-2 and Cops-2 were
the 3 species-speciﬁc loci used to develop and evaluate
real-time PCR assays for the speciﬁc detection of C. hom-
inis and C. parvum.
Sequence data for each locus (Chos-1, Chos-2 and
Cops-2) from all available C. hominis and C. parvum iso-
lates (3 C. hominis UKH3, UKH4, UKH5 and 5 C. par-
vum UKP2, UKP3, UKP6, UKP7, UKP8) were retrieved
and aligned separately (for each species) using BioEdit
version 7.0.9.0 (http://www.mbio.ncsu.edu/BioEdit/bioe
dit.html). Primer sequences were selected to amplify
fragments of interest and appropriate length (70–
150 bp), while avoiding undesirable molecular interac-
tions such as cross reactivity or self-annealing. Primer
length, annealing temperature, %GC content and the
potential for undesirable molecular interactions were
assessed using the Primer Express software program
(Applied Biosystems). The predicted PCR products were
analyzed in silico and no orthologs were found in other
Cryptosporidium spp. MGB hydrolysis probes were
designed according to the optimum criteria: probe hav-
ing an annealing temperature 10C higher than the pri-
mers and avoiding runs of identical nucleotides and
nucleotides likely to quench the reporter ﬂuorescence.
Figure 1. Subtelomeric sequence data alignment at the 50-end of chromosome 5 reveals signiﬁcant sequence incongruence between C.
hominis and C. parvum. Subtelomeric sequence data extending <30,000bp inwards from the 50-telomeric end of chromosome 5 was
extracted from newly-sequenced whole genome sequences for C. parvum subtype IIaA15G2R1 (UKP6) and C. hominis subtype IaA14R3
(UKH4). Sequences were aligned and compared using the Artemis Comparison Tool (ACT).16 Orthologous coding sequences were inde-
pendently validated through The European Molecular Biology Open Software Suite (EMBOSS) Stretcher pairwise sequence alignment of
nucleotide ORFs.18






























Primers and probes sequences and characteristics are
presented in Table 1. For Chos-1, 2 different reverse pri-
mers with a common forward primer and probe were
tested. For Chos-2, 2 different forward primers with a
common reverse primer and probe were tested and for
Cops-2, a single forward and reverse primer and probe
were used. Primer and probe sequences were checked for
cross-reactions with non-target sequences on the GenBank
database using the Basic Local Alignment Search Tool
(BLAST; http://www.ncbi.nlm.nih.gov/blast/Blast.cgi). No
complete (both primers and probe) cross reactions with
non-Cryptosporidium sequences were detected. Primers
and probes (all MGB-non-ﬂuorescent quencher, NFQ
probes) were ordered from Life Technologies.
The primer and probe sets were tested in a singleplex
real-time PCR format. PCR conditions were TaqMan
Environmental Master Mix 2.0 (ABI, Life Technologies),
600 nM of each primer and 100 nM probe. Cycling con-
ditions were 95C for 10 min, 95C for 15 seconds and
60C for 1 min, 50 cycles. PCRs were run on a Rotorgene
thermocycler (Qiagen). Additionally, 2 primer and probe
sets were evaluated in a duplex format for the detection
of single and dual C. parvum and C. hominis infections.
Each real time assay was evaluated using target and
non-target genomic DNA from Cryptosporidium species
and genotypes isolated from human and animal infec-
tions, which included human infective species (such as
C. cuniculus and C. viatorum) as well as non-human
infective species (such as C. andersoni, C. baileyi and C.
bovis). All samples were from anonymised clinical
human and animal sources and provided by the Crypto-
sporidium Reference Unit (Table 2).
While optimising PCR conditions, a small number of
samples were tested using the primer sets in a conven-
tional PCR format. This resulted in DNA ampliﬁcation
from species other than C. hominis and C. parvum (data
not shown). The ampliﬁed bands were very faint and did
not allow sequence analysis of PCR products. However,
the use of probe-based real-time PCR format substan-
tially increased the speciﬁcity of the assay. Real-time
PCR results presented as Ct values are summarised in
Table 2. Ct values ranged from 22.30 for TU502 isolate
detection using Chos-1 assay to 38.44 for UKH15 detec-
tion using Chos-2 assay. Overall, only C. hominis and C.
cuniculus were detected using Chos-1 and Chos-2
primer-probe sets. This result is not surprising because
C. cuniculus is closely related to C. hominis and has been
documented to amplify using C. hominis assays.17 For
Cops-2, only C. parvum DNA was ampliﬁed. However,
one of the 7 C. parvum isolates tested (UKP12) did not
amplify using the Cops-2 assay. Our results support the
species speciﬁcity of these detection assays within the
genus Cryptosporidium, demonstrated by the testing of a
comprehensive panel of human and non-human infec-
tive Cryptosporidium species and genotypes. This speci-
ﬁcity is conferred by the use of primers and probes in a
real time PCR format.
The performance of a duplex assay for the simulta-
neous detection of both C. hominis and C. parvum was
assessed using Chos2-F2 and Cops-2 primers and
probes. This is particularly important for clinical settings
as the duplex PCR would allow detection of both human
pathogens in a single test at a decreased cost and time
compared to individual singleplex PCRs. Individual C.
hominis and C. parvum DNA as well as an artiﬁcially
mixed DNA sample were tested using singleplex and
duplex formats. The samples were correctly identiﬁed by
both assay formats, but the duplex format was associated
with some increase in Ct values compared with those
from the simplex PCR (Table 3). This is a well-known
trade off of the multiplex PCR. However, for the Cops-2
assay the Ct difference between singleplex and duplex
formats was negligible, showing that no competition was
occurring when a duplex format is used.
Table 1. Sequences of forward (F) and reverse (R) primers and probes (T) designed to investigate the potential of Chos-1 and Chos-2 for
the speciﬁc detection of C. hominis and Cops-2 for the speciﬁc detection of C. parvum.
Assay name Primer - Probe Sequence (50-30) nt Tm % GC SIZE
Chos-1 Chos-1F AAATTCACGATTAGCACGACCAG 23 59.2 43 140 bp
Chos-1R TCAATCGGAAATCCACAGAACTACT 25 59.1 40
Chos-1T CCTCTTGAGCTTGCACC 17 69 59
Chos-1R2 Chos-1F AAATTCACGATTAGCACGACCAG 23 59.2 43 127 bp
Chos-1R2 GTAGTGAAATATCCTTTTGGAGTATGC 27 56.8 37
Chos-1T CCTCTTGAGCTTGCACC 17 69 59
Chos-2 Chos-2F GTTCTCAAATTTTGGTTCGCTTG 23 58.8 39 139 bp
Chos-2R TTCTTGTTCAATTGCCATAAGCA 23 58.4 35
Chos-2T CGTTTCAAGTCGTGCATC 18 69 50
Chos-2F2 Chos-2F2 CGCATATGCAAATCAGTTCTCAA 23 58.9 39 167 bp
Chos-2R TTCTTGTTCAATTGCCATAAGCA 23 58.4 35
Chos-2T CGTTTCAAGTCGTGCATC 18 69 50
Cops-2 Cops-2F AAGTCGGAAGCCATAATGATCC 22 58.1 45 148 bp
Cops-2R GTAAAAGCACTTGTTTCTCCAAAATG 26 58.5 35































Comparative genomics are an important aspect of the
post-genomic era. Analysis of genome sequences is con-
tinuously improving our understanding of pathogen
biology, pathogenicity, evolution and host adaptation.
Comparative genomics also allow identiﬁcation of con-
served and speciﬁc genes. We exploited the increasing
numbers of published Cryptosporidium genome sequen-
ces to identify putative unique genes that are likely to be
involved in virulence and host adaptation. Subsequently,
we developed assays based on these genes as speciﬁc
detection tools. Our previous attempt had a limited suc-
cess as only one C. hominis speciﬁc gene was found.6
This was mainly attributed to the low quality of the
TU502 genome sequence available at the time. Techno-
logical advances have enabled the generation of an ever
increasing number of genome sequences of improved
quality.8,15 These improvements are likely to contribute
to more accurately predicted species-speciﬁc genes.
Indeed, assays targeting these genes were conﬁrmed
experimentally as species-speciﬁc as shown by our
results. The use of probe-based real-time PCR assay dra-
matically increased the speciﬁcity of the assays.
These novel real-time PCR assays for the detection of
C. hominis and C. parvum were evaluated using a com-
prehensive panel of human and non-human infective
Cryptosporidium species and genotypes. Only DNA from
C. parvum for real time PCR Cops-2 assay and C. homi-
nis and C. cuniculus for Chos-1 and Chos-2 real time
PCR assays were ampliﬁed. However, further speciﬁcity
assessment needs to be performed using DNA from
other human-infective parasites likely to be present in
human stool samples such as Giardia duodenalis, Cyclo-
spora cayetanensis, Entamoeba histolytica/dispar, Toxo-
plasma gondii, Blastocystis hominis and Dientamoeba
fragilis. Further validation work needs to be undertaken,
including assessment of analytical and diagnostic sensi-
tivity and speciﬁcity, repeatability and reproducibility, as
well as consideration of clinical and epidemiological
application prior to use these assays in a clinical setting.
For the Cops-2 assay, 1 out the 7 C. parvum isolates
tested (UKP12) did not amplify. The reason for this is
unknown. It could be due to sequence variation, DNA
quality or quantity or presence of inhibitors, although
the latter is unlikely as the sample ampliﬁed using other
detection targets. Therefore, it would be useful to include
an internal positive control in any diagnostic PCR
based assay. The positive control could target a
Table 2. Real time PCR results using a comprehensive Cryptosporidium DNA panel from clinical and animal sources. Results are pre-
sented as Ct values.
Species and isolate gp60 subtype Chos-1 Chos-2 Chos-2F2 Chos-1R2 Cops-2
C. hominis TU502 IaA25R3 22.30 27.72 25.27 26.33 neg
C. hominis UKH15 IbA10G2 31.71 38.44 32.25 30.53 neg
C. hominis UKH14 IaA14R3 26.35 34.42 26.66 26.67 neg
C. hominis UKH6 IdA30 27.33 32.28 27.11 27.22 neg
C. cuniculus UKCU13 Va 26.10 30.68 27.64 26.78 neg
C. cuniculus UKCU14 Vb 30.12 35.04 32.27 31.64 neg
C. parvum Moredun IIaA17G1R1 neg neg neg neg 27.72
C. parvum UKP12 IIcA5G3 neg neg neg neg neg
C. parvum UKP13 IIcA5G3 neg neg neg neg 28.86
C. parvum UKP35 IIaA15G2R1 neg neg neg neg 32.97
C. parvum UKP36 IIaA17G1R1 neg neg neg neg 28.40
C. parvum UKP37 IIdA24G1 neg neg neg neg 29.34
Natural co-infection C. hominis and C. parvum UKHP1 IIdA15G1 30.02 33.27 30.68 31.86 33.19
neg neg neg neg neg
C. felis UKFEL3 nk neg neg neg neg neg
C. canis UKCAN1 nk neg neg neg neg neg
C. andersoni UKAND1 nk neg neg neg neg neg
C. baileyi UKBLY1 nk neg neg neg neg neg
C. viatorum UKVIA2 nk neg neg neg neg neg
C. bovis UKBOV1 nk neg neg neg neg neg
Skunk gt UKSK1 nk neg neg neg neg neg
C.meleagridis UKMEL7 nk neg neg neg neg neg
C.meleagridis UKMEL11 nk neg neg neg neg neg
C. ubiquitum UKUB7 nk neg neg neg neg neg
C. ubiquitum UKUB7 nk neg neg neg neg neg
Horse gt UKHOR1 nk neg neg neg neg neg
Note. gt: genotype, nkDnot known, or not applicable. Neg: negative PCR result
Table 3. Real time PCR results (Ct values) comparing single and
duplex Chos-2F2 and Cops-2 assays.
Singleplex assays Duplex assays
Cryptosporidium species and isolate Chos-2F2 Cops-2 Chos-2F2 Cops-2
C. hominis UKH15 32.25 neg 35.14 neg
C. parvum UKP36 neg 28.4 neg 28.96
Artiﬁcial mix C. hominis
and C. parvum
nk nk 36.57 29.64
No template control neg neg neg neg
Note. nkDnot known. Neg: negative PCR result Figure legend.






























Cryptosporidium conserved gene and the performance of
the modiﬁed assay will need to be assessed.
While extensively characterized genes continue to be
the targets of choice for the detection of human infective
Cryptosporidium species, identiﬁcation and validation of
species-speciﬁc genes are sometimes preferable, espe-
cially when investigating host adaptation and evolution.
Additionally, the use of these loci is likely to add robust-
ness to the assay especially in comparison to detection
and typing assays relying on small sequence variation
and even on a single nucleotide polymorphism for suc-
cessful ampliﬁcation and sequence analysis. More genes
continue to be discovered in the post genomic era and
are likely to contribute to major breakthroughs in the
ﬁght against infectious diseases.
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